Effective inactivated influenza vaccine for the elderly using a single-stranded RNA-based adjuvant. 2021

Yoo-Jin Bang, and So-Hee Hong, and Hyo-Jung Park, and Hye Won Kwak, and Yu-Sun Lee, and Jae-Yong Kim, and Hyeong-Jun Park, and Seo-Hyeon Bae, and Hye-Jung Kim, and Yun-Hee Kim, and Hae Li Ko, and Sang-In Park, and Hun Kim, and Gyeongjoo Park, and Man-Seong Park, and Jun Chang, and Jae-Hwan Nam
Department of Medical and Biological Sciences, The Catholic University of Korea, Bucheon, Gyeonggi-do, Republic of Korea.

There is an unmet need for new influenza vaccine strategies that compensate for impaired vaccine responses in elderly individuals. Here, we evaluated the effectiveness of a single-stranded RNA (ssRNA) as an adjuvant to enhance the efficacy of inactivated influenza vaccine (IIV) in mouse models. Immunization with the ssRNA along with IIV reduced viral titers as well as pathological and inflammatory scores in the lungs after influenza challenge in aged mice. ssRNA induced balanced Th1/Th2 responses with an increase in IgA titers. Moreover, the ssRNA adjuvant markedly increased the frequency of influenza HA-specific T cells and IFN-γ production along with the expression of genes related to innate and adaptive immune systems that could overcome immunosenescence in aged mice. Our findings indicate that ssRNA is an efficient vaccine adjuvant that boosts cellular and humoral immunity in aged mice, demonstrating its potential as a novel adjuvant for currently available influenza virus vaccines for elderly individuals.

UI MeSH Term Description Entries
D007252 Influenza Vaccines Vaccines used to prevent infection by viruses in the family ORTHOMYXOVIRIDAE. It includes both killed and attenuated vaccines. The composition of the vaccines is changed each year in response to antigenic shifts and changes in prevalence of influenza virus strains. The flu vaccines may be mono- or multi-valent, which contains one or more ALPHAINFLUENZAVIRUS and BETAINFLUENZAVIRUS strains. Flu Vaccine,Influenzavirus Vaccine,Monovalent Influenza Vaccine,Universal Flu Vaccine,Universal Influenza Vaccine,Flu Vaccines,High-Dose Trivalent Influenza Vaccine,Influenza Vaccine,Influenza Virus Vaccine,Influenza Virus Vaccines,Influenzavirus Vaccines,Intranasal Live-Attenuated Influenza Vaccine,LAIV Vaccine,Monovalent Influenza Vaccines,Quadrivalent Influenza Vaccine,Trivalent Influenza Vaccine,Trivalent Live Attenuated Influenza Vaccine,Universal Flu Vaccines,Universal Influenza Vaccines,Flu Vaccine, Universal,High Dose Trivalent Influenza Vaccine,Influenza Vaccine, Monovalent,Influenza Vaccine, Quadrivalent,Influenza Vaccine, Trivalent,Influenza Vaccine, Universal,Intranasal Live Attenuated Influenza Vaccine,Vaccine, Flu,Vaccine, Influenza,Vaccine, Influenza Virus,Vaccine, Influenzavirus,Vaccine, LAIV,Vaccine, Monovalent Influenza,Vaccine, Quadrivalent Influenza,Vaccine, Trivalent Influenza,Virus Vaccine, Influenza
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D001800 Blood Specimen Collection The taking of a blood sample to determine its character as a whole, to identify levels of its component cells, chemicals, gases, or other constituents, to perform pathological examination, etc. Blood Specimen Collections,Collection, Blood Specimen,Collections, Blood Specimen,Specimen Collection, Blood,Specimen Collections, Blood
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000276 Adjuvants, Immunologic Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. Immunoactivators,Immunoadjuvant,Immunoadjuvants,Immunologic Adjuvant,Immunopotentiator,Immunopotentiators,Immunostimulant,Immunostimulants,Adjuvant, Immunologic,Adjuvants, Immunological,Immunologic Adjuvants,Immunological Adjuvant,Adjuvant, Immunological,Immunological Adjuvants
D000367 Age Factors Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time. Age Reporting,Age Factor,Factor, Age,Factors, Age
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies

Related Publications

Yoo-Jin Bang, and So-Hee Hong, and Hyo-Jung Park, and Hye Won Kwak, and Yu-Sun Lee, and Jae-Yong Kim, and Hyeong-Jun Park, and Seo-Hyeon Bae, and Hye-Jung Kim, and Yun-Hee Kim, and Hae Li Ko, and Sang-In Park, and Hun Kim, and Gyeongjoo Park, and Man-Seong Park, and Jun Chang, and Jae-Hwan Nam
September 2020, Vaccine,
Yoo-Jin Bang, and So-Hee Hong, and Hyo-Jung Park, and Hye Won Kwak, and Yu-Sun Lee, and Jae-Yong Kim, and Hyeong-Jun Park, and Seo-Hyeon Bae, and Hye-Jung Kim, and Yun-Hee Kim, and Hae Li Ko, and Sang-In Park, and Hun Kim, and Gyeongjoo Park, and Man-Seong Park, and Jun Chang, and Jae-Hwan Nam
July 2019, Biomedical and environmental sciences : BES,
Yoo-Jin Bang, and So-Hee Hong, and Hyo-Jung Park, and Hye Won Kwak, and Yu-Sun Lee, and Jae-Yong Kim, and Hyeong-Jun Park, and Seo-Hyeon Bae, and Hye-Jung Kim, and Yun-Hee Kim, and Hae Li Ko, and Sang-In Park, and Hun Kim, and Gyeongjoo Park, and Man-Seong Park, and Jun Chang, and Jae-Hwan Nam
September 2014, Vaccine,
Yoo-Jin Bang, and So-Hee Hong, and Hyo-Jung Park, and Hye Won Kwak, and Yu-Sun Lee, and Jae-Yong Kim, and Hyeong-Jun Park, and Seo-Hyeon Bae, and Hye-Jung Kim, and Yun-Hee Kim, and Hae Li Ko, and Sang-In Park, and Hun Kim, and Gyeongjoo Park, and Man-Seong Park, and Jun Chang, and Jae-Hwan Nam
August 2022, Viruses,
Yoo-Jin Bang, and So-Hee Hong, and Hyo-Jung Park, and Hye Won Kwak, and Yu-Sun Lee, and Jae-Yong Kim, and Hyeong-Jun Park, and Seo-Hyeon Bae, and Hye-Jung Kim, and Yun-Hee Kim, and Hae Li Ko, and Sang-In Park, and Hun Kim, and Gyeongjoo Park, and Man-Seong Park, and Jun Chang, and Jae-Hwan Nam
March 2024, Biochemistry. Biokhimiia,
Yoo-Jin Bang, and So-Hee Hong, and Hyo-Jung Park, and Hye Won Kwak, and Yu-Sun Lee, and Jae-Yong Kim, and Hyeong-Jun Park, and Seo-Hyeon Bae, and Hye-Jung Kim, and Yun-Hee Kim, and Hae Li Ko, and Sang-In Park, and Hun Kim, and Gyeongjoo Park, and Man-Seong Park, and Jun Chang, and Jae-Hwan Nam
April 1998, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
Yoo-Jin Bang, and So-Hee Hong, and Hyo-Jung Park, and Hye Won Kwak, and Yu-Sun Lee, and Jae-Yong Kim, and Hyeong-Jun Park, and Seo-Hyeon Bae, and Hye-Jung Kim, and Yun-Hee Kim, and Hae Li Ko, and Sang-In Park, and Hun Kim, and Gyeongjoo Park, and Man-Seong Park, and Jun Chang, and Jae-Hwan Nam
April 2019, Archives of virology,
Yoo-Jin Bang, and So-Hee Hong, and Hyo-Jung Park, and Hye Won Kwak, and Yu-Sun Lee, and Jae-Yong Kim, and Hyeong-Jun Park, and Seo-Hyeon Bae, and Hye-Jung Kim, and Yun-Hee Kim, and Hae Li Ko, and Sang-In Park, and Hun Kim, and Gyeongjoo Park, and Man-Seong Park, and Jun Chang, and Jae-Hwan Nam
January 2017, PloS one,
Yoo-Jin Bang, and So-Hee Hong, and Hyo-Jung Park, and Hye Won Kwak, and Yu-Sun Lee, and Jae-Yong Kim, and Hyeong-Jun Park, and Seo-Hyeon Bae, and Hye-Jung Kim, and Yun-Hee Kim, and Hae Li Ko, and Sang-In Park, and Hun Kim, and Gyeongjoo Park, and Man-Seong Park, and Jun Chang, and Jae-Hwan Nam
February 2020, Viruses,
Yoo-Jin Bang, and So-Hee Hong, and Hyo-Jung Park, and Hye Won Kwak, and Yu-Sun Lee, and Jae-Yong Kim, and Hyeong-Jun Park, and Seo-Hyeon Bae, and Hye-Jung Kim, and Yun-Hee Kim, and Hae Li Ko, and Sang-In Park, and Hun Kim, and Gyeongjoo Park, and Man-Seong Park, and Jun Chang, and Jae-Hwan Nam
January 2014, Vaccine,
Copied contents to your clipboard!